Reduced Ang-1 and Ang-2 and increased Ang-2/Ang-1 are detected in patients with CM (Conroy et al., 2012; Eisenhut, 2012), which is consistent with the pathophysiological changes of activation and dysfunction of ECs among CM patients. This evidence concerns the gene ANGPT2 and cutaneous mastocytosis.